Liver Fibrosis Drugs Market Size
The global liver fibrosis drugs market was valued at USD 15.38 billion in 2024 and is expected to reach USD 36.51 billion by 2032
During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 11.41%, primarily driven by rising prevalence, drug advancements, investments.
This growth is driven by factors such as increasing prevalence of chronic liver diseases and advancements in drug development and approvals
𝐕𝐢𝐬𝐢𝐭 𝐮𝐬 𝐧𝐨𝐰 -
1 View